Your Inflammation Has a Genetic Root. Here's What Your DNA Reveals.

TNF-alpha is your immune system’s megaphone. It’s a chemical messenger that amplifies inflammatory signals throughout your body, telling immune cells to mobilize and tissues to increase protective responses. In normal amounts, TNF-alpha is necessary and protective. But when TNF-alpha production runs too high, inflammation spreads systemically.

The TNF -308G>A variant (rs1800629) is carried by roughly 30% of people with European ancestry. This single nucleotide swap increases the amount of TNF-alpha your immune cells produce in response to triggers. People with the A allele experience a significantly more aggressive inflammatory response to infections, injuries, and immune provocations.

You experience this as persistent joint pain that doesn’t improve with rest, skin flares that spread beyond the initial trigger, or a general sense of low-grade sickness even when you’re not acutely ill. Systemic inflammation becomes your baseline.

If TNF-alpha is your immune system’s megaphone, IL-6 is the amplifier that makes the signal louder. IL-6 creates a feedback loop that extends inflammatory responses and drives neuroinflammation, meaning inflammation literally reaches your brain. This is why chronic inflammation often comes with brain fog and mood changes.

The IL6 -174G>C variant (rs1800795) is present in roughly 40% of the population. People carrying the C allele produce more IL-6 when their immune system is activated. Elevated IL-6 doesn’t just amplify physical inflammation; it directly drives cognitive symptoms and mood dysregulation.

You notice this as persistent brain fog alongside your inflammatory symptoms, mood swings that don’t match your circumstances, or a flattened sense of motivation and joy even when life is otherwise good. Inflammation isn’t just a physical problem for you; it’s affecting your mental clarity and emotional resilience.

SOD2 is an antioxidant enzyme that lives inside your mitochondria and neutralizes the free radicals produced during energy production. When SOD2 is working efficiently, it keeps oxidative stress contained. When it’s not, free radicals accumulate and trigger inflammatory signaling. In this way, SOD2 dysfunction doesn’t cause inflammation directly; it allows oxidative stress to cause inflammation.

The SOD2 Val16Ala variant (rs4880) is carried by roughly 40% of the population in homozygous form. The Ala variant produces slightly less efficient SOD2 enzyme. This means your mitochondria are generating more oxidative stress than average, and that stress is constantly triggering your inflammatory pathways.

You experience this as fatigue that doesn’t improve with sleep, recovery that takes longer after exercise, and inflammation that seems almost impossible to lower despite consistent effort. You’re dealing with chronic oxidative stress at the cellular level, which no diet change addresses directly.

MTHFR converts dietary folate into the methylated form your cells actually use. This methylated folate is then used to produce SAM-e, your body’s master methyl donor. SAM-e is required for producing glutathione (your primary intracellular antioxidant), regulating inflammatory gene expression, and maintaining immune tolerance. When MTHFR isn’t efficient, methylation stalls and your ability to regulate inflammation and antioxidant defense declines.

The MTHFR C677T variant is carried by roughly 35% of the population. People with one copy produce 30-40% less methylated folate; those with two copies produce 70% less. Reduced methylation capacity means you cannot produce adequate glutathione or regulate inflammatory gene expression efficiently, so your inflammatory baseline stays elevated.

You experience this as inflammation that doesn’t respond to standard anti-inflammatory supplements, fatigue that worsens with B vitamins (because your body can’t process them properly), and a general feeling that your body is struggling to keep up metabolically. Your immune system never fully downregulates because your methylation machinery is overwhelmed.

GSTM1 is a detoxification enzyme that helps your liver remove chemical compounds and toxins from your bloodstream. It also protects cells from oxidative damage by working with glutathione, your master antioxidant. Many people are born with a complete deletion of the GSTM1 gene (called GSTM1 null), meaning they produce no GSTM1 enzyme at all. These people are more vulnerable to toxin accumulation and oxidative stress.

The GSTM1 null genotype is present in roughly 50% of the population. People with null genotype have no GSTM1 enzyme, while others have one or two functional copies. GSTM1 null individuals accumulate chemical toxins and experience amplified oxidative stress, which directly drives inflammatory activation.

You experience this as skin reactions to chemical exposures others tolerate fine, inflammation that worsens when you’re exposed to air pollution or household chemicals, or reactions to supplements and medications that seem disproportionate to the dose. Your immune system is essentially working overtime trying to handle exposures that your detoxification system can’t efficiently clear.

CRP is not actually an inflammatory mediator like TNF or IL-6; it’s a protein your liver produces in response to inflammatory signals. CRP is also used clinically as a marker of systemic inflammation. But here’s the critical part: some people’s CRP gene promoter is more responsive to inflammatory signals than others. This means they produce more CRP for the same inflammatory trigger, and their baseline CRP level is chronically elevated.

The CRP +1444C>T variant (rs3091244) is carried by roughly 30% of the population. People with the T allele have a more active CRP promoter, meaning their liver responds more aggressively to inflammatory signals by increasing CRP production. This doesn’t cause inflammation, but it means your inflammatory state is more easily detected and more persistent once triggered.

You experience this as elevated CRP on blood tests even when you feel fine, or CRP that stays high long after an infection or injury that should have resolved. Your inflammatory markers seem disproportionate to how sick you actually feel, and they’re slow to improve with standard interventions.